f Targeted Photodynamic Therapy for Drug-Resistant Pulmonary Tuberculosis through Mycolic Acid and Cyclohexadiene-Aminophenyl Interactions

References

1. AlsayedS.S.R. GunosewoyoH. Tuberculosis: Pathogenesis, current treatment regimens and new drug targets.Int. J. Mol. Sci.2023246520210.3390/ijms24065202 36982277
   [Google Scholar]
2. SiaJ.K. RengarajanJ. Immunology of Mycobacterium tuberculosis infections.Microbiol. Spectr.2019747.4.610.1128/microbiolspec.GPP3‑0022‑2018 31298204
   [Google Scholar]
3. SotgiuG. CentisR. D’ambrosioL. MiglioriG.B. Tuberculosis treatment and drug regimens.Cold Spring Harb. Perspect. Med.201555a01782210.1101/cshperspect.a017822 25573773
   [Google Scholar]
4. O’RiordanK. SharlinD.S. GrossJ. ChangS. ErrabelliD. AkilovO.E. KosakaS. NauG.J. HasanT. Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection.Antimicrob. Agents Chemother.20065051828183410.1128/AAC.50.5.1828‑1834.2006 16641456
   [Google Scholar]
5. AllisonR.R. MoghissiK. Photodynamic therapy (PDT): PDT mechanisms.Clin. Endosc.2013461242910.5946/ce.2013.46.1.24 23422955
   [Google Scholar]
6. CorreiaJ.H. RodriguesJ.A. PimentaS. DongT. YangZ. Photodynamic therapy review: Principles, photosensitizers, applications, and future directions.Pharmaceutics2021139133210.3390/pharmaceutics13091332 34575408
   [Google Scholar]
7. GunaydinG. GedikM.E. AyanS. Photodynamic therapy—current limitations and novel approaches.Front Chem.2021969169710.3389/fchem.2021.691697 34178948
   [Google Scholar]
8. AgostinisP. BergK. CengelK.A. FosterT.H. GirottiA.W. GollnickS.O. HahnS.M. HamblinM.R. JuzenieneA. KesselD. KorbelikM. MoanJ. MrozP. NowisD. PietteJ. WilsonB.C. GolabJ. Photodynamic therapy of cancer: An update.CA Cancer J. Clin.201161425028110.3322/caac.20114 21617154
   [Google Scholar]
9. MishchenkoT. BalalaevaI. GorokhovaA. VedunovaM. KryskoD.V. Which cell death modality wins the contest for photodynamic therapy of cancer?Cell Death Dis.202213545510.1038/s41419‑022‑04851‑4 35562364
   [Google Scholar]
10. ChenP. ShiM. FengG.D. LiuJ.Y. WangB.J. ShiX.D. MaL. LiuX.D. YangY.N. DaiW. LiuT.T. HeY. LiJ.G. HaoX.K. ZhaoG. A highly efficient Ziehl-Neelsen stain: Identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid.J. Clin. Microbiol.20125041166117010.1128/JCM.05756‑11 22238448
    [Google Scholar]
11. AzizB. AzizI. KhurshidA. RaoufiE. EsfahaniF.N. JalilianZ. MozafariM.R. TaghaviE. IkramM. An overview of potential natural photosensitizers in cancer photodynamic therapy.Biomedicines202311122410.3390/biomedicines11010224 36672732
    [Google Scholar]
12. MansooriB. MohammadiA. DoustvandiA.M. MohammadnejadF. KamariF. GjerstorffM.F. BaradaranB. HamblinM.R. Photodynamic therapy for cancer: Role of natural products.Photodiagn. Photodyn. Ther.20192639540410.1016/j.pdpdt.2019.04.033 31063860
    [Google Scholar]
13. SainiR.K. SinghD. BhagwanS. Sonika, SinghI. KadyanP.S. Photovoltaic characterization of dye sensitized solar cells based on TiO 2 nanoparticles using triarylmethane dyes as photosensitizers.J. Nanoelect. Optoelect.201611217518210.1166/jno.2016.1892
    [Google Scholar]
14. OkunoM. YamanaK. KawamuraS. NishimuraK. HinoS. KawasakiR. IkedaA. Selective photodynamic activity of tetrakis(4‐aminophenyl)porphyrins with and without acetyl protecting groups on cancer and normal cells.Chemistry20232947e20230138510.1002/chem.202301385 37334625
    [Google Scholar]
15. WangQ. SunM. LiC. LiD. YangZ. A computer-aided chem-photodynamic; drugs self-delivery system for synergistically enhanced cancer therapy.Asian J. Pharm. Sci.2021162203212
    [Google Scholar]
16. VilchèzeC. KremerL. Acid-fast positive and acid-fast negative Mycobacterium tuberculosis : The koch paradox.Microbiol. Spectr.2017525.2.1510.1128/microbiolspec.TBTB2‑0003‑2015 28337966
    [Google Scholar]
17. SelvakumarN. RahmanF. RajasekaranS. NarayananP.R. FriedenT.R. Inefficiency of 0.3% carbol fuchsin in ziehl-neelsen staining for detecting acid-fast bacilli.J. Clin. Microbiol.20024083041304310.1128/JCM.40.8.3041‑3043.2002 12149374
    [Google Scholar]
18. BayotM.L. MirzaT.M. SharmaS. Acid Fast Bacteria.StatPearls.Treasure Island (FL): StatPearls Publishing2023
    [Google Scholar]
19. DunnJ.J. StarkeJ.R. RevellP.A. Laboratory diagnosis of mycobacterium tuberculosis infection and disease in children.J. Clin. Microbiol.20165461434144110.1128/JCM.03043‑15 26984977
    [Google Scholar]
20. ZhaoY.L. LiuY.H. JiangG.L. ChanW.Y. YipC.W. KamK.M. Variations in quality of carbol fuchsin stains collected from routine tuberculosis laboratories.Int. J. Tuberc. Lung Dis.2009131126129 19105890
    [Google Scholar]
21. ZhangH. LiuM. FanW. SunS. FanX. The impact of Mycobacterium tuberculosis complex in the environment on one health approach.Front. Public Health20221099474510.3389/fpubh.2022.994745 36159313
    [Google Scholar]
22. ChengY. XieJ. LeeK.H. GaurR.L. SongA. DaiT. RenH. WuJ. SunZ. BanaeiN. AkinD. RaoJ. Rapid and specific labeling of single live Mycobacterium tuberculosis with a dual-targeting fluorogenic probe.Sci. Transl. Med.201810454eaar447010.1126/scitranslmed.aar4470 30111644
    [Google Scholar]
23. RudolphD. RedingerN. SchwarzK. LiF. HädrichG. CohrsM. DaileyL.A. SchaibleU.E. FeldmannC. Amorphous drug nanoparticles for inhalation therapy of multidrug-resistant tuberculosis.ACS Nano202317109478948610.1021/acsnano.3c01664 37160267
    [Google Scholar]
24. SlaterB.K. KimD. ChandP. XuY. ShaikhH. UndaleV. A current perspective on the potential of nanomedicine for anti-tuberculosis therapy.Trop. Med. Infect. Dis.20238210010.3390/tropicalmed8020100 36828516
    [Google Scholar]
25. KiaP. RumanU. PratiwiA.R. HusseinM.Z. Innovative therapeutic approaches based on nanotechnology for the treatment and management of tuberculosis.Int. J. Nanomed.2023181159119110.2147/IJN.S364634 36919095
    [Google Scholar]
26. KumarM. VirmaniT. KumarG. DeshmukhR. SharmaA. DuarteS. BrandãoP. FonteP. Nanocarriers in tuberculosis treatment: Challenges and delivery strategies.Pharmaceuticals20231610136010.3390/ph16101360 37895831
    [Google Scholar]
27. BourguignonT. Godinez-LeonJ.A. GrefR. Nanosized drug delivery systems to fight tuberculosis.Pharmaceutics202315239310.3390/pharmaceutics15020393 36839715
    [Google Scholar]
28. WangX. WangX. LeiX. HeY. XiaoT. Photodynamic therapy: A new approach to the treatment of nontuberculous mycobacterial skin and soft tissue infections.Photodiagn. Photodyn. Ther.20234310364510.1016/j.pdpdt.2023.103645 37270047
    [Google Scholar]
29. ChangJ.E. OakC.H. SungN. JheonS. The potential application of photodynamic therapy in drug-resistant tuberculosis.J. Photochem. Photobiol. B2015150606510.1016/j.jphotobiol.2015.04.001 25907636
    [Google Scholar]
30. ZhangZ. LiuJ. WanC. LiuP. WanH. GuoZ. TongJ. CaoX. Successful treatment of tuberculosis verrucosa cutis with fester as primary manifestation with photodynamic therapy and anti-tubercular drugs.Photodiagn. Photodyn. Ther.20223810276310.1016/j.pdpdt.2022.102763 35189390
    [Google Scholar]
31. WalvekarP. GannimaniR. GovenderT. Combination drug therapy via nanocarriers against infectious diseases.Eur. J. Pharm. Sci.201912712712114110.1016/j.ejps.2018.10.017 30342173
    [Google Scholar]
32. OlszowyM. Nowak-PerlakM. WoźniakM. Current strategies in photodynamic therapy (PDT) and photodynamic diagnostics (PDD) and the future potential of nanotechnology in cancer treatment.Pharmaceutics2023156171210.3390/pharmaceutics15061712 37376160
    [Google Scholar]